And except as required by law, STRATA Skin Sciences disclaims any obligation to publicly update or revise any information to ...

RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA ( 1) +11.8%, ADJUSTED NET INCOME ( 2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION ...

Q3 2025 Earnings Call Transcript November 10, 2025 Pagaya Technologies Ltd. misses on earnings expectations. Reported EPS is ...

Expanded data for VCN-01 (zabilugene almadenorepvec) in metastatic pancreatic ductal adenocarcinoma (PDAC) from the VIRAGE Phase 2b trial ...

Heidi Crane noted a $0.3 million increase in net interest expense, which slightly offset operational gains. Net Revenue -- ...

Fathom's total revenue increased 37.7% to $115.3 million for the third quarter of 2025, up from $83.7 million in the third ...

CEO Treace stated, "we are not growing our line the way we anticipated for the year," while also noting case volume growth in ...

The CPSC and FDA have announced a series of baby product recalls families need to be aware of. This post appeared first in ...

The results were weighed down by declines at its linear entertainment networks and lower theatrical distribution, offset by ...

Technology has greatly advanced over the 21st century, and techno-thrillers like Ex Machina and Tenet expose the thrills and ...

Jolt synergy targets -- Management reaffirms expectations for Jolt to contribute an $11 million EBITDA run rate by calendar ...

Third Quarter 2025 Financial Results Net revenue in the third quarter of 2025 increased 58% to $11.8 million, compared to $7.5 million in the third quarter of 2024. The increase was due to an increase ...